Linaclotide Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
AZN | C | Astrazeneca PLC | -0.25 | |
IRWD | F | Ironwood Pharmaceuticals, Inc. | -1.77 |
Related Industries: Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
Related Stock Lists:
Gastrointestinal
Acid
Anemia
Angina
Antibodies
Asthma
Autoimmune And Inflammatory Disease
Bipolar Disorder
Breast Cancer
Cancer
Cardiovascular Disease
Central Nervous System Disorders
Cholesterol
Chronic Condition
Chronic Idiopathic Constipation
Chronic Kidney Disease
Chronic Obstructive Pulmonary Disease
Constipation
Coronavirus
Depressive Disorder
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
MEDX | B | Horizon Kinetics Medical ETF | 5.73 | |
PPH | B | Market Vectors Pharmaceutical ETF | 4.91 | |
FLUD | C | Franklin Liberty Ultra Short Bond ETF | 4.07 | |
IBBQ | B | Invesco Nasdaq Biotechnology ETF | 3.95 | |
ACTV | C | LeaderShares Activist Leaders ETF | 3.59 |
Compare ETFs
Related Industries:
Drug Manufacturers - Major
Drug Manufacturers - Specialty & Generic
Related Stock Lists:
Gastrointestinal
Acid
Anemia
Angina
Antibodies
Asthma
Autoimmune And Inflammatory Disease
Bipolar Disorder
Breast Cancer
Cancer
Cardiovascular Disease
Central Nervous System Disorders
Cholesterol
Chronic Condition
Chronic Idiopathic Constipation
Chronic Kidney Disease
Chronic Obstructive Pulmonary Disease
Constipation
Coronavirus
Depressive Disorder
- Linaclotide
Linaclotide (marketed under the trade name Linzess in the US and Mexico, and as Constella elsewhere) is a drug used to treat irritable bowel syndrome with constipation and chronic constipation with no known cause.
It has a black box warning about the risk of serious dehydration in children in the US; the most common adverse effects in others are gastrointestinal.It is an oligo-peptide agonist of guanylate cyclase 2C and remains in the GI tract after it is taken orally. It was approved in the US and Europe in 2012.It is priced at around $400 for thirty pills in the US and is marketed by Allergan in most of the world and by Astellas in Asia; Ironwood Pharmaceuticals was the originator.
Recent Comments
- TraderMike on Bollinger Band Squeeze
- TraderMike on Bollinger Band Squeeze
- OpenCat584 on Bollinger Band Squeeze
- Dr_Duru on Expansion Breakout
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
From the Blog
Featured Articles